All Publications — CAMS Oxford Institute

Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Multimodal, device-based therapeutic targeting of the cardiovascular autonomic nervous system.

Paton JFR. et al, (2026), Nature reviews. Cardiology, 23, 255 - 278

Human-derived cardiac-neural microtissues reveal catecholaminergic polymorphic ventricular tachycardia is also a disease of the sympathetic neuron.

Li N. et al, (2026), The Journal of physiology

Anti-arrhythmic targeting of sympathetic stellate ganglion P2X3 receptors.

Bussey CT. et al, (2026), The Journal of physiology, 604, 1067 - 1087

Neurocardiology: translational advancements and potential

Herring N. et al, (2025), The Journal of Physiology, 603, 1729 - 1779

Molecular and cellular neurocardiology in heart disease

Habecker BA. et al, (2025), The Journal of Physiology, 603, 1689 - 1728

Preface Editorial for Special Issue Dedicated to Jeffrey L. Ardell (1952-2025) Cardiac Neurobiology: Concepts to Clinic.

Paterson DJ. and Shivkumar K., (2025), The Journal of physiology, 603, 1683 - 1686

The cardiac sympathetic co-transmitter neuropeptide-Y is pro-arrhythmic in human cardiomyocytes by lengthening activation-recovery interval

Bloxsom R. et al, (2024), European Heart Journal, 45

Bioelectronics for neurocardiology: diagnosis and therapeutics.

Paterson DJ. et al, (2023), European heart journal, 44, 4822 - 4825

Human induced pluripotent stem cell-derived cardiac myocytes and sympathetic neurons in disease modelling

Li N. et al, (2023), Philosophical Transactions of the Royal Society B: Biological Sciences, 378

Abnormal Cyclic Nucleotide Signaling at the Outer Mitochondrial Membrane In Sympathetic Neurons During the Early Stages of Hypertension

Li D. et al, (2022), Hypertension, 79, 1374 - 1384

Uncovering Anti-Arrhythmic Potential of Stellate Ganglion Purinergic Receptors.

Bussey CT. et al, (2022), FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 36 Suppl 1

A governing equation for rotor and wavelet number in human clinical ventricular fibrillation: Implications for sudden cardiac death.

Dharmaprani D. et al, (2022), Heart rhythm, 19, 295 - 305

Macrophages Can Drive Sympathetic Excitability in the Early Stages of Hypertension

Neely OC. et al, (2022), Frontiers in Cardiovascular Medicine, 8

Post-Ganglionic Sympathetic Neurons can Directly Sense Raised Extracellular Na+ via SCN7a/Nax.

Davis H. et al, (2022), Frontiers in physiology, 13

Healthy cardiac myocytes can decrease sympathetic hyperexcitability in the early stages of hypertension.

Davis H. et al, (2022), Frontiers in synaptic neuroscience, 14

Load More

1
2
3
4
5
6
7
...
»